Differences in survival outcome for patients with ovarian cancer in Sc
otland led to an investigation of whether these differences were due t
o variation in presenting prognostic features or to the organisation a
nd delivery of cancer services. A retrospective study of all 533 cases
of ovarian cancer registered in Scotland in 1987 was carried out. Aft
er adjustment for age, stage, pathology, degree of differentiation and
presence of ascites, survival improved when patients (1) were first s
een by a gynaecologist (P<0.05); (2) were operated on by a gynaecologi
st (P<0.05); (3) had residual disease of less than 2 cm post-operative
ly (P<0.001); (4) were prescribed platinum chemotherapy (P<0.05); and
(5) were referred to a joint clinic (P<0.001). When gynaecologists ope
rated the likelihood of smaller residual disease increased (P<0.001).
The improved survival from management by a multidisciplinary team at a
joint clinic was not solely due to the prescription of platinum chemo
therapy. The results of this study support the contents of the 1991 De
partment of Health report on present acceptable practice in the manage
ment of ovarian cancer, circulated to gynaecologists and surgeons in S
cotland in 1992. The new finding that in a common cancer management by
a multidisciplinary team at a joint clinic directly affects survival
requires urgent attention.